Class / Patent application number | Description | Number of patent applications / Date published |
564225000 | Amidines (i.e., HN=CH-HNH, wherein substition may be made for hydrogen only) | 19 |
20080200725 | PREPARATION OF AMINO ACID-FATTY ACID ANHYDRIDES - The present invention describes compounds produced from an amino acid molecule and a fatty acid molecule. The compounds being in the form of amino-fatty acid compounds being bound by an anhydride linkage, or mixtures thereof made by reacting amino acids or derivatives thereof with an appropriate fatty acid previously reacted with a thionyl halide. The administration of such molecules provides supplemental amino acids with enhanced bioavailability and the additional benefits conferred by the specific fatty acid. | 08-21-2008 |
564226000 | Amidino hydrazines or hydrazones (i.e., HNH-N=CH-HNH or HN=CH-NH-HNH, wherein substitution may be made for hydrogen only) | 1 |
564227000 | Guanyl hydrazines or hydrozones (i.e., HNH-N=C(-HNH)-HNH or HN=C(-HNH)-NH HNH, wherein substitution may be made for hydrogen only) | 1 |
564228000 | Benzene ring containing | 1 |
20100036166 | Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases - The invention relates to chlorine Guanabenz derivatives for treating Huntington's disease and other polyglutamine expansion associated diseases. More specifically, it relates to the use of the molecule of formula (I) wherein R═H or Cl and the phenyl group is at least substituted twice, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for treating polyglutamine expansion associated diseases. | 02-11-2010 |
564229000 | Amidoximes (i.e., HON=CH-HNH, wherein substitution may be made for hydrogen only) | 1 |
20110021835 | AMINO ACID DERIVATIVES USED AS PHARMACEUTICAL SUBSTANCES - The invention relates to a method for improving bioavailability of pharmaceutical substances and for allowing the pharmaceutical substances to permeate the blood-brain barrier, the pharmaceutical substances having at least one or more amidine, guanidine, N-hydroxyamidine (amidoxime) or N-hydroxyguanidine functions. The invention also relates to medicaments containing the correspondingly modified pharmaceutical substances. | 01-27-2011 |
564230000 | Guanidines (i.e., HN=C(-HNH)-HNH, wherein substitution may be made for hydrogen only) | 14 |
564233000 | Biguanides (i.e., HN=C(-HNH)-NH-(HNH-)C=NH, wherein substitution may be made for hydrogen only) | 4 |
564234000 | Benzene ring containing | 4 |
20090270653 | PROCESS FOR PRODUCING 1-(3,4-DICHLOROBENZYL)-5-OCTYLBIGUANIDE OR A SALT THEREOF - The present invention provides a process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof, the process comprising reacting 1-cyano-3-octylguanidine or a salt thereof, with 3,4-dichlorobenzylamine or a salt thereof, in an ester-based organic solvent. According to the present invention, the reaction can be carried out at a low temperature using general-purpose equipment, and 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof can be produced in a high yield by a safe and easy process. | 10-29-2009 |
20090287021 | METHOD AND APPARATUS FOR PREPARING A SOLUTION OF A SHEAR SENSITIVE MATERIAL - The invention provides a novel apparatus and method for preparing a solution of a shear sensitive material. | 11-19-2009 |
20110263901 | Process of Preparation of Proguanil - Disclosed herein is the process for the preparation of 1-(4-chlorophenyl)-5-isopropyl-biguanide hydrochloride (Proguanil hydrochloride), Formula-I, an antimalarial agent. | 10-27-2011 |
564235000 | Plural rings containing | 1 |
20080306301 | BROAD SPECTRUM ANTIMICROBIAL PURIFICATION MATERIALS AND METHODS FOR PURIFYING FLUIDS - An antimicrobial composition for use in water, air, and other fluid treatment applications is provided. The composition includes a biguanide dihydrate compound, such as a chlorhexidine dihydrate, which exhibits broad spectrum antimicrobial activity. | 12-11-2008 |
564237000 | Benzene ring containing | 4 |
20090005595 | Gentisic Acid for Stabilising 123-I Radiopharmaceuticals - The present invention relates to stabilised | 01-01-2009 |
20100274052 | PREPARATION OF RADIOLABELLED HALOAROMATICS VIA POLYMER-BOUND INTERMEDIATES - According to a first aspect of the invention, a process is disclosed for the preparation of radiolabelled haloaromatic compounds. According to a second aspect of the invention, intermediate precursor insoluble polymer compounds used in the preparation of the radiolabelled haloaromatics are disclosed, as well as processes for the preparation of the intermediate precursor insoluble polymer compounds. | 10-28-2010 |
564238000 | Benzene ring bonded directly to guanidine nitrogen | 2 |
20130060064 | METHOD AND SYNTHESIS - The present invention provides a method for the preparation of a radiolabeled guanidine derivative, in particular wherein the radiolabeled guanidine derivative is a positron emission tomography (PET) tracer. Certain intermediates useful in said method are also provided, as well as means for carrying out said method in an automated fashion. The method of the invention provides advantages over known methods for the preparation of radiolabeled guanidine derivatives. | 03-07-2013 |
20140243555 | METHOD FOR THE SYNTHESIS OF 18F-LABELLED MOLECULES - The present invention provides a method for the synthesis of 18F-labelled biomolecules, which is amenable to automation. The present invention also provides a cassette for automating the method of the invention. The method of the present invention provides numerous advantages over the prior art methods. One less purification step is required as compared with known methods. Also, in a preferred embodiment, one less reagent is required as a particular reagent is employed in two different steps. The chemistry process is thereby simplified, the cost of goods is reduced and the burden of validation and documentation of reagents required for GMP clinical production is minimised. | 08-28-2014 |
564240000 | Acyclic | 6 |
20100130783 | USE OF AGMATINE FOR PROTECTION OF RETINAL GANGLION CELLS - A use method of agmatine or a pharmaceutically allowable salt thereof, and a pharmaceutical composition comprising the same are disclosed. The method and pharmaceutical composition of the present invention can effectively cure or prevent eye diseases preferably including glaucoma, retinopathy, and optic neuropathy associated with apoptosis in retinal ganglion cells (RGCs), particularly hypoxia-induced or tumor necrosis factor-α (TNF-α)-induced apoptosis. | 05-27-2010 |
20140155654 | Forming Spherical Crystal Habit - Methods for forming spherical crystal habit are shown. A needle-shaped crystal habit, a solvent, and a surfactant are combined and dissolved forming a first solution. The first solution and an anti-solvent are combined forming a second solution. The second solution is cooled. Spherical crystal habit is formed. | 06-05-2014 |
20140256986 | Creatinol sulfate and synthesis method thereof - A chemical compound of creatinol sulfate is formed by chemically reacting N-methyl-amino-ethanol, cyanamide, with sulfuric acid to produce the creatinol sulfate with relatively higher yield rate and purity, wherein the mol ratio of N-methyl-amino-ethanol, sulfuric acid, and cyanamide is approximately 2:1:2. | 09-11-2014 |
564241000 | Guanidine per se or salt thereof | 3 |
20110105797 | Creatinol sulfate and synthesis method thereof - A chemical compound of creatinol sulfate is formed by chemically reacting N-methyl-amino-ethanol, cyanamide, with sulfuric acid to produce the creatinol sulfate with relatively higher yield rate and purity, wherein the mol ratio of N-methyl-amino-ethanol, sulfuric acid, and cyanamide is approximately 2:1:2. | 05-05-2011 |
20130035509 | Novel Use of the Guanidinium Cation and Light-Emitting Component - The invention relates to a use of the guanidinium cation and to a light-emitting component. This invention for the first time describes matrix materials and emitters for uses in organic electrochemical light-emitting cells containing a guanidinium cation unit. Guanidinium groups as a cationic system promise a wide electrochemical window and hence stable components. The route to guanidinium systems is described in detail in the literature. | 02-07-2013 |
20140256987 | Creatinol O-phosphate and synthesis method thereof - A creatinol O-phosphate is formed by chemically reacting a creatinol sulfate of creatinol compound with sulfuric acid to form a protected creatinol sulfate as a transition state of the synthesis process of the creatinol O-phosphate, wherein the protected creatinol is further reacted with one of P | 09-11-2014 |
564244000 | Benzene ring containing | 2 |
564245000 | N(prime)-aryl formimidines (i.e., benzene-N=CH-HNH, wherein substitution may be made for hydrogen, including those bonded directly to the benzene ring only) | 1 |
20130079557 | SUBSTITUTED PHENYLAMIDINES AND THE USE THEREOF AS FUNGICIDES - The present invention relates to oxime ether-, hydrazone- or azomethine-substituted phenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and also to a composition for this purpose, comprising the amidines according to the invention. Furthermore, the invention relates to a method for controlling unwanted microorganisms by applying the compounds according to the invention to the microorganisms and/or their habitat. | 03-28-2013 |
564246000 | Additional nitrogen attached indirectly to amidine nitrogen by nonionic bonding | 1 |
20140114089 | NOVEL PROCESS FOR THE MANUFACTURE OF 4-AMINOBENZOAMIDINE DIHYDROCHLORIDE - The present invention relates to a process for the preparation of 4-aminobenzoamidine (4-AMBA) salts of general formula (I) | 04-24-2014 |